Clinical Trials · NCT01137695
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Cheryl Rosenfeld, DO
- Enrollment
- 40
- Start date
- May 2010
- Locations
- 3 sites, United States
- Primary endpoint
- Glucose control